A phase 3 clinical trial suggests that patients who used a 50 mg dose of oral semaglutide (Rybelsus) showed 15.5% weight reduction after 68 weeks
Our team checks your eligibility and pairs you with a suitable provider
The 'specials' (named-patient) route which allows certain unlicensed medicines to be supplied on a prescriber's request does not apply to unapproved investigational compounds such as retatrutide
Month 13 What to expect: Weight loss becomes more noticeable Average loss: 48 lbs per month Appetite control improves Dose titration increase effectiveness Energy and digestion start to feel more balanced By now, clients usually feel the difference, not just on the scale, but in their daily routine
Husain M, Birkenfeld AL, Donsmark M, Dungan K, Eliaschewitz FG, Franco DR, Jeppesen OK, Lingvay I, Mosenzon O, Pedersen SD
Lixisenatide was largely outcompeted by newer GLP-1s that offer stronger A1C and weight-loss results